Merck Sharp & Dohme LLC
Rahway, New Jersey, United States
Purpose
To validate whether inhibition of Plasmepsin IX/X prevent malaria infection and allow acquisition of functional liver immunity in healthy volunteers
Division
Global Health
Date
August 2026
Region Served
AFRICA, GLOBAL
Committed amount
$991,383
Grant topic
Malaria
Duration (months)
5
Grantee location
Rahway, New Jersey, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.